VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s share price traded down 2.9% during trading on Tuesday . The stock traded as low as C$0.17 and last traded at C$0.17. 105,487 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 289,703 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 11.8 %
The firm has a market capitalization of C$24.33 million, a price-to-earnings ratio of -4.63 and a beta of 0.39. The company’s 50 day moving average price is C$0.10 and its 200 day moving average price is C$0.13. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- High Flyers: 3 Natural Gas Stocks for March 2022
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Are Some of the Best Large-Cap Stocks to Buy?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
- Consumer Staples Stocks, Explained
- Joby Aviation: From Prototype to Profitability
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
